// App-Quantinova.ai

647 : NF-kB associates with tyrosine kinase inhibitor resistance in chronic myeloid leukemia

Researchers

Presenter

  • Andres J. Rubio

Principal Investigators

  • Idaly M. Olivas

  • Alfonso E. Bencomo

  • Mayra A. Gonzalez

  • Joshua J. Lara

  • Rebecca Ellwood

  • Carme Ripoll-Fiol

  • Georgios Nteliopoulos

  • Alistair Reid

  • Dragana Milojkovic

  • Jane Apperley

  • Jamshid Sorouri-Khorashad

  • Anna M. Eiring

Medical Centers

  • TTUHSC-El Paso, El Paso, TX

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic Myelogenous Leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Cluster of Differentiation 34

  • Interleukin 6

Drug/Treatment

  • Tocilizumab

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved